Trial Profile
A randomized trial of postoperative adjuvant chemotherapy with capecitabine versus capecitabine/PSK following curative resection for stage III colon cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Polysaccharide K (Primary) ; Capecitabine
- Indications Colon cancer
- Focus Adverse reactions
- 15 Oct 2011 New trial record